Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Torm Plc Cl A (NQ: TRMD )

34.24 -1.12 (-3.17%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,103,455
Open 34.01
Bid (Size) 34.07 (60)
Ask (Size) 34.45 (1)
Prev. Close 35.36
Today's Range 33.78 - 34.34
52wk Range 25.28 - 40.47
Shares Outstanding 82,311,299
Dividend Yield 17.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cassava Sciences, enVVeno Medical And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
Can the "dogs of the Dow" strategy work on the longer list of Nasdaq stocks? 
Via The Motley Fool

Performance

YTD
+8.87%
+8.87%
1 Month
-7.76%
-7.76%
3 Month
-11.68%
-11.68%
6 Month
-2.67%
-2.67%
1 Year
+23.34%
+23.34%

More News

Read More
High Dividend Yields Make These 2 Shipping Stocks Stand Out
Via MarketBeat
Topics Economy Energy World Trade
Exposures Fossil Fuels Interest Rates Tariff
Top 4 Energy Stocks That May Explode In Q3
Via Benzinga
TRMD Stock Earnings: TORM Meets EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Elevating Investor Returns: Energy Transfer Delivers Strong Performance and Growing Profits
Via Benzinga
Responding to Performance Concerns: Equitrans Midstream Manages Decreased Earnings and Adjusts Dividends
Via Benzinga
NuStar Energy: The Catalyst for Consistent Growth and Investor Rewards
Via Benzinga
Jim Cramer Calls Axsome A 'Double Or Nothing Stock,' Says SAP Is 'Incredible'
Via Benzinga
TRMD Stock Earnings: TORM Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Dividend Diamonds in the Rough: 7 Undervalued Income Stocks
Via InvestorPlace
In a market where value is scarce, NASDAQ:TRMD offers a refreshing opportunity with its solid fundamentals.
Via Chartmill
NASDAQ:TRMD, an undervalued stock with good fundamentals.
Via Chartmill
Wall Street’s Favorite Dividend Stocks? 7 Tickers That Are Practically Money Machines
Via InvestorPlace
Why Is Verb Technology (VERB) Stock Up 267% Today?
Via InvestorPlace
Dear AMZN Stock Fans, Mark Your Calendars for March 20
Via InvestorPlace
TRMD Stock Earnings: TORM Beats EPS, Beats Revenue for Q4 2023
Via InvestorPlace
Evercore ISI Group Maintains Outperform Rating for TORM: Here's What You Need To Know
Via Benzinga
NASDAQ:TRMD stands out as a stock that provides good value for the fundamentals it showcases.
Via Chartmill
Overcoming Challenges and Adapting: Hess Midstream Navigates to Reward InvestorsDriving Profitability and Investor Rewards: Hess Midstream Delivers Strong Performance and Growing Profits
Via Benzinga
Western Midstream Demonstrates Strong Performance and Increased Profits, Maximizing Returns for Shareholders
Via Benzinga
3 Life-Changing Stocks Poised for Phenomenal Growth
Via InvestorPlace
Surpassing Expectations: EnLink Midstream Unleashes Growth Potential and Rewards Investors
Via Benzinga
Top 5 Energy Stocks That May Crash This Quarter
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.